Lior ShaltielCEO at NurExone BiologicSpeaker
Agenda Sessions
From Antibodies to EVs and siRNA Therapy: A Comparative Analysis of AbbVie and NurExone's approaches to Effective Spinal Cord Injury Treatment
, 11:30amView SessionBeyond mAbs: The Next Wave of Therapeutic Innovation for a New Era
, 3:00pmView Session